Möchten Sie immer auf dem neuesten Stand bleiben?

VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — Biotechs that went public in Q1 2026 raised a median of $287.5 million each; and nearly every one...

SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that it will present an invited...

GEVORKYAN, a.s. vďaka posilneniu pozície na európskom a špeciálne talianskom trhu získala nové projekty.   Dve desiatky nových výrobkov úspešne prešli testami pre renomovanú rakúsku technologickú...

GEVORKYAN, a.s. díky posílení pozice na evropském a zejména italském trhu získala nové projekty. Dvě desítky nových výrobků úspěšně prošly testy pro renomovanou rakouskou technologickou společnost,...

GEVORKYAN, a.s. has secured new projects as a result of strengthening its position in the European market, particularly in Italy. Two dozen new products successfully passed testing for a renowned...

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Application and Regional Analysis - Analysis and Forecast, 2025-2035" has been added to ...

Exousia Pro, OTCPK: MAJI, announces the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market.

KELLIE MATZINGER, MICROBIOLOGY AND STERILIZATION AUTHORITY, LEADS FIRST ONSITE’S NEW LIFE SCIENCES DIVISION. GREENWOOD VILLAGE, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- First Onsite Property...

SOUTH SAN FRANCISCO, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen...